A recent study by ETF Channel reveals that Johnson & Johnson (JNJ) ranks as the #8 stock pick among the 30 companies in the Dow Jones Industrial Average based on analyst recommendations. In comparison to the broader S&P 500 index, JNJ holds the #116 position out of 500 stocks.
On Tuesday, JNJ’s stock was down approximately 1% during midday trading, amid a market where competitors such as Eli Lilly (LLY) decreased by about 1.5% and Novartis (NVS) fell by around 0.2%.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
